You are here

EPİLASYON AMACIYLA PRİLOKAİN UYGULANAN BİR HASTADA GELİŞEN METHEMOGLOBİNEMİ

A CASE OF METHEMOGLOBINEMIA INDUCED BY THE ADMINISTRATION OF PRILOCAINE PRIOR TO AN EPILATION PROCEDURE

Journal Name:

Publication Year:

Keywords (Original Language):

Abstract (2. Language): 
The iron in the hemoglobin molecule is in ferrous state (Fe++). The oxidation of iron from ferrous to ferric (Fe+++) state causes methemoglobinemia. This reaction decreases the oxygen-carrying capacity of hemoglobin leading to hypoxemia of the peripheral tissues and even to death in severe cases. Methemoglobinemia is frequently related to chemical substances. However, hereditary or idiopathic cases have also been described. Methemoglobinemia due to local anesthetic drugs may occur especially in newborn infants. Here, we presented an adult case in which methemoglobinemia developed after the administration of prilocaine prior to an epilation procedure
Abstract (Original Language): 
Normal flartlarda hemoglobinde bulunan demir iki de¤erlidir (Fe++). Hemoglobindeki demirin okside olup üç de¤erli (Fe+++) duruma geçmesiyle methemoglobinemi oluflur. Bu reaksiyon, dokuda hipoksemiye yol açar. A¤›r vakalarda hemoglobinin, oksijen ve karbondioksit tafl›ma kapasitesindeki ciddi bozulma nedeniyle ölüm meydana gelebilir. Methemoglobinemi s›kl›kla kimyasal maddelerle temas sonras› görülmekle beraber, genetik, besinlere ba¤l› ve idiopatik olarak da bulunabilir. Lokal anestetiklere ba¤l› methemoglobinemi daha çok yenido¤anlarda karfl›lafl›lan bir durumdur. Bu yaz›da epilasyon ifllemi öncesi prilokain uygulanan ve sonras›nda akut methemoglobinemi geliflen eriflkin bir olgu sunulmufltur.
19-21

REFERENCES

References: 

KAYNAKLAR
1. Beutler E. Methemoglobinemia and other causes of cyanosis.
Ed: Beutler E, Lichtman MA, Coller BS, Kipps TJ, Seligsohn U.
Williams Hematology, 6 th Edition 2001, pages: 611-617.
2. Centers for Disease Control and Prevention: MMWR, Prilocaine-
induced methemoglobinemia-Wisconsin, 1993; 43: 655.
3. Coleman MD, Coleman NA. Drug-induced methaemoglobinemia.
Drug Safety 1996; 14: 394-405.
4. Curry S. Methemoglobinemia. Ann Emerg Med 1982; 2: 214-
221.
5. Darling RC, Roughton FJW. The effect of methemoglobin on
the equilibrium between oxygen and hemoglobin. Am J Physiol
1942; 137: 56.
6. Frayling IM, Addison GM, Chattergee K. Methaemoglobinaemia
in children treated with prilocaine-lignocaine cream. BMJ
1990; 301: 153-154.
7. Jaffe ER: Methemoglobinemia in the differential diagnosis of
cyanosis. Hosp Pract 1985; 15: 92-110.
8. Matthews PJ. Co-oximetry. Respir Care Clin North Am 1995; 1:
47-68.
9. Osterhoudt KC. Methemoglobinemia. Ed: Ford M, Delaney K,
Ling L, Erickson T. Ford: Clinical Toxicology, 1st edition, W. B.
Saunders Company, Philadelphia 2001; pp: 211-217.
10. Schroeder TH, Dieterich HJ, Muhlbauer B. Methemoglobinemia
after axillary block with bupivacaine and additional injection
of lidocaine in the operative field. Acta Anaesthesiol Scand
1999; 43: 480-482.
11. Tetzlaff JE. The pharmacology of local anesthetics. Anesthesiol
Clin North America 2000; 18: 217-233.
12. Tunal› A. Methemoglobinemiler. ‹ç Hastal›klar› Kitab›. Ed:
Öbek A. 4. bask›, Bursa 1990, sayfa: 741-742.
13. Watcha MF, Connor MT, Hing AV. Pulse oximetry in methemoglobinemia.
Am J Dis Child 1989; 143: 845-847.
14. Wrignt RO, Lewander WJ, Woolf AD. Methemoglobinemia:
etiology, pharmacology, and clinical management: Ann Emerg
Med 1999; 34: 646-656.

Thank you for copying data from http://www.arastirmax.com